e-learning
resources
Vienna 2003
Sunday 28.09.2003
Pharmacological treatment strategies in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Flow-volume responsiveness to bronchodilators in COPD
L. Forkert, D. O'Donnell (Kingston, Canada)
Source:
Annual Congress 2003 - Pharmacological treatment strategies in COPD
Session:
Pharmacological treatment strategies in COPD
Session type:
Thematic Poster Session
Number:
442
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Forkert, D. O'Donnell (Kingston, Canada). Flow-volume responsiveness to bronchodilators in COPD. Eur Respir J 2003; 22: Suppl. 45, 442
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
COPD and airway responsiveness to beta-agonists
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Year: 2007
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV
1
and FEV
1
in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005
Airway inflammation and inhaled corticosteroids in COPD
Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017
Year: 2017
Assessing regional airways responses to inhaled bronchodilators in asthmatics
Source: Annual Congress 2010 - Airways mechanics in different applications
Year: 2010
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016
Year: 2017
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Year: 2017
Bronchodilator treatment for asthma and COPD
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010
Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008
Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Paradoxical bronchoconstriction after administration of beta-2 agonist bronchodilators in COPD patients
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Variability in asthma severity among steroid-naive patients previously receiving short-acting beta
2
-agonists
Source: Eur Respir J 2003; 22: Suppl. 45, 410s
Year: 2003
Changes in airway and tissue mechanics in ventilated COPD patients after nebulized bronchodilator agent
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007
COPD: Comparison of bronchodilator responsiveness with glycopyrronium and salbutamol
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002
Nebulized bronchodilator therapy in stable COPD – effect on quality of life and spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 64s
Year: 2006
How the bronchodilatator in COPD patients works
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept